Stroke

Published on 05/05/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 10255 times

Stroke

Stroke follows heart disease and cancer as the third leading cause of death in developed countries, accounting for 10% of overall mortality in the UK. It is defined clinically as an acute neurological deficit of vascular origin that lasts more than 24 hours or causes death.

Types of stroke

Stroke is caused by inadequate tissue perfusion or ischaemia (Greek: isch-, restriction; haema, blood). The brain is particularly sensitive to ischaemia because neurons have a high metabolic rate and can only survive a few minutes without oxygen and glucose. Tissue death as a result of inadequate blood flow (e.g. due to an occluded blood vessel) is called infarction (Latin: infarctus, stuffed). The area of dead tissue is referred to as ‘an infarct’. There are two main types of stroke (Figs 10.1 and 10.2):

In both types of stroke the brain tissue normally supplied by the vessel is suddenly deprived of blood and its function is lost. This causes focal neurological deficits that develop very rapidly (e.g. sudden weakness or loss of speech) and abrupt onset is the clinical hallmark of stroke. In haemorrhagic stroke, there may also be mechanical damage, such as tearing and compression of brain tissue, caused by blood escaping under arterial pressure.

Ischaemic stroke

Ischaemic stroke can be divided into five groups based on cause: (i) large-artery atherosclerosis; (ii) cardioembolism; (iii) small vessel occlusion; (iv) other defined cause; and (v) unknown cause (cryptogenic stroke). This classification is derived from a multicentre trial of acute stroke treatment (‘TOAST’) in the 1990s and continues to be widely used in UK stroke trials. The ‘other defined cause’ category incorporates many uncommon and rare causes of stroke including abnormalities of blood coagulation, infectious diseases, arterial damage and inflammatory disorders.

Large vessel and cardioembolic stroke

Cerebral blood vessels may be occluded by an embolus (Greek: embolos, wedge or plug). This is a small piece of coagulated blood (or occasionally some other material such as fat) that travels in the circulation and lodges in the vascular tree of the brain. Emboli often originate from the heart (cardioembolic stroke) in association with valve disease or an abnormal heart rhythm (Clinical Box 10.1). Disease in the neck vessels or aortic arch may also give rise to emboli.

Some ischaemic strokes are caused by coagulation of blood within a cerebral vessel, termed in situ thrombosis (Greek: thrombos, blood clot) or large artery intracranial occlusive disease. This is more common in people of Asian and African origin, but is increasingly recognized in Caucasians.

Small vessel disease

Small vessel disease is particularly common in patients with arterial hypertension together with other vascular risk factors (e.g. diabetes, cigarette smoking, elevated cholesterol). High blood pressure damages the arterial wall and its smooth muscle is gradually replaced by collagen, termed hyaline arteriosclerosis. In some cases there is vessel wall necrosis with accumulation of lipid-laden foam cells, which is referred to as lipohyalinosis.

Both types of pathology cause arteriosclerosis or ‘hardening’ of the arteries (Greek: sklerōs, hard). Sclerotic vessels are unable to dilate in response to reduced flow, leading to lacunar infarcts (see Ch. 12, Figs 12.18 and 12.19). These are small areas of ischaemic tissue damage (often in the basal ganglia or internal capsule) measuring less than 1 cm in diameter (Latin: lacūna, hole or gap). Small vessel disease is also an important cause of vascular cognitive impairment and dementia (Ch. 12).

Haemorrhagic stroke

Spontaneous intracerebral haemorrhage is more common in people with high blood pressure and frequently occurs in the basal ganglia, cerebellum or pons (Fig. 10.2A). However, the incidence of hypertensive intracerebral haemorrhage is declining in the UK and USA and an increasingly important cause is cerebral amyloid angiopathy, particularly in the elderly (see Ch. 12, Clinical Box 12.5). This is caused by deposition of amyloid beta peptide in the walls of cortical and meningeal arteries, leading to atypical (or lobar) haemorrhages that are close to the cortical surface (Fig. 10.2B).

Up to a third of spontaneous intracranial haemorrhages are caused by rupture of an aneurysm (a dilatation in the wall of an artery). Since the cerebral blood vessels travel and branch within the subarachnoid space, this results in subarachnoid haemorrhage (Clinical Box 10.2). Aneurysms that rupture in the substance of the brain may cause devastating brain damage or sudden death.

Blood supply to the brain

The brain is supplied by two pairs of arteries that arise from branches of the aortic arch (Fig. 10.4):

The arteries at the base of the brain are linked by communicating vessels to form the circle of Willis. This gives rise to anterior, middle and posterior cerebral arteries on each side, which supply most of the cerebral hemisphere. The cerebral blood supply can be divided into anterior and posterior circulations (Fig. 10.5A).

Anterior circulation

The internal carotid artery divides at the base of the brain, giving rise to the middle cerebral artery (MCA) and the anterior cerebral artery (ACA). The MCA is the larger of the two and receives 80% of the internal carotid blood flow. For this reason, cardiogenic emboli are much more likely to enter the MCA than the ACA. The middle cerebral artery continues laterally between the frontal and temporal lobes and emerges from the lateral sulcus to supply most of the hemispheric convexity (Figs 10.6A and 10.7).

The anterior cerebral artery passes forward and medially to meet its partner between the cerebral hemispheres. It winds around the corpus callosum and supplies the medial aspect of the hemisphere as far back as the parieto-occipital sulcus (Figs 10.6 and 10.8). Posterior to this point the posterior cerebral artery takes over to supply the occipital lobe. Perforating branches of the anterior circulation supply the optic radiations, so that anterior circulation strokes may cause a contralateral visual field defect.

Circle of Willis

The circle of Willis is a polygonal arrangement of blood vessels surrounding the optic chiasm and pituitary stalk. It connects the anterior and posterior circulations via the single anterior communicating artery and the paired posterior communicating arteries (Figs 10.5B and 10.9). The circle of Willis shows considerable anatomical variation and is incomplete in 50% of people. It is an example of a collateral circulation, an arrangement of interconnected vascular channels permitting blood flow via an alternative route in the event of an obstruction. Interconnections between vessels exist elsewhere (e.g. between the distal territories of the three main cerebral blood vessels) but are not always effective, particularly in the elderly. Some structures do not have a collateral blood supply (e.g. the internal capsule and basal ganglia) and are therefore more vulnerable to stroke.

Perforating vessels

The circle of Willis gives rise to a number of central perforating vessels which supply the internal substance of the brain. Perforating vessels from the anterior circulation enter the brain just lateral to the optic chiasm on each side, via the anterior perforated area. A second group arises from the posterior circulation and enters the brain at the interpeduncular fossa of the midbrain, via the posterior perforated area. The anterior group includes the lenticulostriate vessels (or ‘arteries of stroke’) which supply the basal ganglia and internal capsule (Fig. 10.6A). They are an important site of spontaneous intracerebral haemorrhage and lacunar infarcts (both caused by small-vessel disease).

The arterial territories of the three main cerebral vessels and deep perforating vessels are illustrated in coronal section in Figure 10.10. The regions between territories are the watershed zones and are particularly vulnerable to a sudden reduction in arterial blood pressure. This may lead to a characteristic pattern of watershed infarction at the arterial border zones following profound arterial hypotension (e.g. after cardiorespiratory arrest, anaphylactic shock or major blood loss).

Blood supply to the cerebellum

The cerebellum is supplied by three long circumferential vessels that arise from different parts of the posterior circulation (Figs 10.9 and 10.11):

The posterior inferior cerebellar artery also supplies the lateral medulla. Occlusion of this vessel is associated with the lateral medullary syndrome (Clinical Box 10.3).

image Clinical Box 10.3:   Lateral medullary syndrome

Occlusion of the posterior inferior cerebellar artery (PICA), supplying the lateral part of the medulla, causes: (i) ipsilateral loss of pain and temperature sensation in the face; and (ii) contralateral loss of pain and temperature sensationin in the trunk and limbs. This results from damage to the trigeminal sensory nucleus and spinothalamic tract respectively (see Ch. 4). Sympathetic fibres passing from the hypothalamus to the spinal cord may also be affected, leading to loss of sympathetic innervation to the ipsilateral face. This is one cause of Horner’s syndrome, characterized by ptosis (drooping eyelid), miosis (small, constricted pupil) and facial anhidrosis (loss of sweating). Other features of the lateral medullary syndrome reflect damage to local brain stem structures and connections with the cerebellum: difficulty swallowing, double vision, poor coordination, vertigo and nausea.

Stroke syndromes

For practical purposes, ischaemic strokes can be classified into one of four major clinical categories based on the maximum deficit following a single stroke, illustrated in Figure 10.12:

This system is easy to use and provides useful prognostic information. For example, the proportion of patients dying within the first year in each type is approximately 60% (TACS), 20% (PACS or POCS) and 10% (LACS). In the first week after a stroke, the most common cause of death is raised intracranial pressure due to brain swelling (cerebral oedema); this causes herniation of the cerebellar tonsils through the skull base, compressing the brain stem (which is referred to as ‘coning’, see Ch. 9).

Atherosclerosis

The underlying pathology in a significant proportion of cerebrovascular (and cardiovascular) disease is atherosclerosis. This is a degenerative process affecting medium and large arteries throughout the body (Greek: sklērōsis, hardening). It is almost universal in the developed world, chiefly as a result of lifestyle factors including poor diet, cigarette smoking and lack of exercise.

Atheromatous plaques

The characteristic lesion in atherosclerosis is called an atheroma (from the Latin word for porridge). This is a deposit of lipid-rich material in the vessel wall that develops over many years. The process begins in the innermost (intimal) layer of large arteries and slowly expands. Atheromatous deposits therefore cause progressive stenosis (narrowing) of the vessel (Fig. 10.13). This gradually impinges on the lumen, but may remain asymptomatic for many years. The precursor lesions in atherosclerosis are known as fatty streaks. These are pale areas beneath the arterial endothelium that can be identified in the arteries of children and consist of lipid-laden macrophages.

The distribution of atheromatous plaques is not random. Areas exposed to rapid, turbulent blood flow are particularly susceptible, especially arterial branch-points. These include the aortic arch and large arteries of the neck, both of which may be a source of emboli to the brain (Clinical Box 10.4). Atherosclerosis is also common in the intracranial portion of the internal carotid artery and at the origin and major branch-points of the middle cerebral artery.

Plaque formation

A key factor in plaque formation is dysfunction of the endothelium, which normally releases factors such as nitric oxide that prevent platelet and leukocyte adhesion. Endothelial dysfunction can be caused by toxic agents including aromatic hydrocarbons and free radicals that are present in cigarette smoke. Damage is also caused by physical shearing forces due to high blood pressure and turbulent flow. Platelets adhere to dysfunctional endothelial cells and become activated, releasing cytokines (inflammatory mediators) and platelet derived growth factor (PDGF). This initiates a chronic inflammatory response in the vessel wall.

Plaque progression

Inflammatory mediators released by activated platelets recruit monocytes from the bloodstream. These migrate into the vessel wall and differentiate into macrophages where they take up cholesterol and lipids to become foam cells. Growth factors and cytokines released by foam cells initiate a cascade of pathological events in which there is further accumulation of cholesterol and proliferation of intimal smooth muscle. This process is accelerated if the serum cholesterol is high (Clinical Box 10.5). Smooth muscle cells secrete extracellular matrix proteins including collagen, which generates a tough fibrous cap over the soft plaque core, creating a relatively stable fibrous plaque (Fig. 10.14A). If the fibrous cap ruptures or the overlying endothelial layer becomes ulcerated, the plaque is referred to as complicated (Fig. 10.14B). This may trigger thrombosis, leading to vessel occlusion and stroke.

Stroke management

Several large clinical trials have shown that the best outcomes in stroke care are achieved by dedicated stroke units (or by specialist multidisciplinary stroke teams). Key elements include:

The collective impact of these simple measures is a substantial reduction in long-term neurological impairment, with a 25% increase in the number of people returning to work. A small proportion of patients with ischaemic stroke may be suitable for thrombolysis (Clinical Box 10.6).

Stroke prevention

Acute stroke treatment is currently limited, which increases the importance of preventative measures including the avoidance of known risk factors. Primary prevention aims to avoid a first stroke in someone who is at risk, whereas secondary prevention reduces the likelihood of recurrence.

Risk factors for stroke

Arterial hypertension is the most important factor and clinical trials show that a 5 mmHg reduction in diastolic blood pressure cuts stroke risk by around a third, even in patients with normal blood pressure. Decreasing serum cholesterol is also highly beneficial, and even people with normal levels may benefit from cholesterol-lowering agents such as statins (inhibitors of the cholesterol-synthesizing liver enzyme hydroxy-methyl-glutaryl-CoA reductase). Reduced consumption of saturated animal fats is also helpful, together with increased intake of polyunsaturated vegetable fats and fish oils (containing omega-3 fatty acids). In patients with diabetes, who are particularly predisposed to arterial disease, good control of blood sugar is essential. Daily low-dose aspirin and other antiplatelet agents may also of value (Clinical Box 10.7).

Other factors

Oral contraceptives with a high oestrogen content increase relative stroke risk by enhancing the tendency of blood to coagulate, but since the background risk is tiny in young females, the absolute risk remains extremely low. Elevation of the amino acid homocysteine in the serum, as a result of folate or vitamin B deficiency or in the rare genetic condition homocysteineuria, is also associated with premature vascular disease, but it is not clear if reducing homocysteine levels is beneficial in preventing stroke. Modest alcohol intake may reduce stroke risk (perhaps in part by increasing plasma HDL concentration) but consuming more than two units per day (i) begins to reverse the benefits, (ii) has other negative effects on health and (iii) is an important cause of haemorrhagic stroke in younger people (Fig. 10.15).

Pathophysiology of stroke

The average rate of cerebral blood flow is 50 mL per 100 g of tissue per minute. This high rate of blood flow is required to deliver enough oxygen and glucose to support the intense metabolic demands of neural tissue. If the blood supply fails, neurons begin to die within a few minutes.

The ischaemic cascade (Fig. 10.16)

In acute cerebral ischaemia, perfusion failure leads to energy failure, due to cessation of oxidative phosphorylation within mitochondria. Without fresh blood flowing through the tissue, toxins such as lactic acid and carbon dioxide build up and acidosis develops. Neurons can tolerate ischaemia in the short term by reducing electrochemical activity and minimizing energy consumption, but prolonged or intense ischaemia inevitably leads to cell death.

Failure of the sodium pump

The sodium pump (Na+/K+-ATPase) is responsible for two thirds of the basal energy expenditure of the brain. It works constantly in the background to maintain the intracellular and extracellular sodium and potassium ion concentrations and is therefore essential for electrical activity in nerve cells (see Ch. 6). As the ATP supply falls to critical levels, the sodium pump fails. As a result, the sodium and potassium gradients dissipate and neuronal membranes depolarize. A critical point is reached when cerebral blood flow falls to less than 20% of normal (below 10 mL per 100 g per minute). Depolarized neurons reach their ‘firing thresholds’ and there is large-scale release of neurotransmitters, including the excitatory amino acid glutamate which is toxic at high concentrations.

Calcium and excitotoxicity

As a result of these events the extracellular glutamate concentration is increased to ten times its normal value. At these levels glutamate behaves as an excitotoxin by allowing excessive calcium influx through NMDA channels (which have been liberated from their normal magnesium block) together with contributions from voltage-gated calcium channels and calcium-permeable AMPA receptors (see Chs 7 and 8). Elevation of intracellular calcium is a critical event in neuronal cell death since calcium activates a host of harmful enzymes, including calpains, proteases, phospholipases, endonucleases and nitric oxide synthase (see Ch. 8). The final ‘point of no return’ occurs as plasma membrane integrity is lost and water enters the cell. This is called cytotoxic oedema which causes cell rupture and death, followed by an inflammatory response.

The ischaemic penumbra

Within an hour of stroke onset a necrotic core lesion is established in which the blood flow is below 20% of normal. This is surrounded by a poorly perfused border zone known as the ischaemic penumbra in which blood flow is between 20–40% of normal (Fig. 10.17). Penumbral neurons may remain viable for up to 24 hours and can potentially be salvaged, but if perfusion is not restored the core lesion will gradually expand.

The ischaemic penumbra can be visualized using a combination of perfusion-weighted and diffusion-weighted magnetic resonance imaging (PWI and DWI). A perfusion-weighted MRI scan provides a semi-quantitative measure of cerebral blood flow whereas the diffusion-weighted sequence identifies the densely ischaemic core lesion, by using increased tissue water content as a marker of cytotoxic oedema. Digitally subtracting one from the other gives a PWI–DWI mismatch, which corresponds approximately to the ischaemic penumbra and can usually be identified within six hours of stroke onset.

Neuroprotection

A major aim of basic stroke research is the development of compounds that are able to protect poorly perfused tissue by interfering with the ischaemic cascade or brain inflammatory response. Most of this work is first carried out in animal models, before moving on to clinical trials.

Animal models of stroke

Animal models of cerebral ischaemia most often use laboratory rats, mice or gerbils. Rabbits, dogs and cats have also been used, but there are relatively few trials in non-human primates such as chimpanzees because of the major ethical considerations and considerable expense.

Organotypic cultures

This method employs intact brain slices (e.g. rodent hippocampus) that are maintained in an incubated culture medium. Preparations of this kind can remain viable for as long as six weeks, maintaining normal connectivity and activity (Fig. 10.18A). Cerebral ischaemia can be simulated by combined oxygen–glucose deprivation, producing reproducible lesions that compare well with their in vivo counterparts (Fig. 10.18B). Slice cultures therefore combine many of the positive characteristics of whole animal studies without the major drawbacks of dissociated cell cultures.

Neuroprotective agents

Many neuroprotective agents have been developed to block events in the ischaemic cascade (e.g. excitotoxicity, oxidative stress, calcium overload) and although they work very well in animal models, clinical trials have been uniformly disappointing for numerous reasons (discussed below).

Failure of drug delivery

Agents travelling in the bloodstream may not be able to reach the targeted area of the brain, either due to poor perfusion of ischaemic tissues or failure to cross the blood–brain barrier (see Ch. 5), but this is not relevant in many animal models. Furthermore, side effects of certain drugs can prevent administration of effective doses that are equivalent to those used in preclinical studies.

White matter ischaemia

Another source of difficulty is that the majority of basic science research focuses on protection and salvage of neurons in the cortical grey matter, but a significant burden of pathology following stroke is due to loss of white matter and axonal connections between cortical regions.

Delayed neuronal cell death

In recent years, interest has shifted to the process of delayed neuronal cell death, by which the initial core lesion gradually expands into the ischaemic penumbra. Factors implicated in this process include reperfusion injury, nitric oxide release and delayed apoptosis.

Nitric oxide release

Nitric oxide is one of several reactive oxygen species released in the ischaemic brain and is generated in large quantities on reperfusion. It is synthesized from L-arginine (by inflammatory cells and ischaemic neurons) by various isoforms of nitric oxide synthase (NOS).

Synthesis by endothelial cells is neuroprotective, since it promotes vasodilation and inhibits platelet and leukocyte adhesion, improving cerebral blood flow. Production in neurons and microglial cells is stimulated by inflammatory cytokines and is strongly neurotoxic. Nitric oxide also generates the highly cytotoxic molecule peroxynitrite, ONOO by reacting with superoxide anion, which has been shown to promote apoptosis in the ischaemic penumbra. In keeping with this, inhibition of nitric oxide synthase is neuroprotective in animal models.

Delayed apoptosis

Although the majority of cell death following stroke is necrotic, up to a fifth may be due to programmed cell death (particularly in the ischaemic penumbra). Apoptotic bodies derived from dead neurons have been identified in the reperfused penumbra and inhibitors of apoptosis (e.g. cyclosporin A) are neuroprotective in animal models of stroke. Astrocytes also undergo apoptosis during reperfusion in response to a rise in intracellular calcium, reducing an important source of metabolic support for sublethally injured neurons.